Dear Democracy Now! Visitor: We are an independent, ad-free daily news program that serves millions of viewers and listeners each month. Our show is special because we make it our priority to go where the silence is. We put a spotlight on corporate and government abuses of power and lift up the stories of ordinary people working to make change in extraordinary times. We do all of this with just a fraction of the budget and staff of a commercial news show. We do it without ads, corporate sponsorship or government funding. How is this possible? Only with your support. If everyone who visited our website in the next week donated just $15, we would cover all of our operating costs for the year. We can't do it without you. Please donate today. It takes just a couple of minutes to do your part to make sure Democracy Now! is there for you and everybody else.

Your Donation: $
Tuesday, July 24, 2001 FULL SHOW | HEADLINES | NEXT: People Around the World Express Outrage at Police...
2001-07-24

Public Citizen Accuses the Drug Industry of Falsifying Research Costs While Spending Millions to Fight Lower Drug Prices

download:   Audio Get CD/DVD More Formats
This is viewer supported news

Public Citizen has accused the pharmaceutical industry of overstating the costs of developing new drugs while itspends millions of dollars to lobby against legislation that would rein in prescription drug prices for seniorcitizens and others burdened by soaring drug costs.

The report, released yesterday, adds fuel to Congressional calls for sweeping reforms of drug prices, including drugbenefits for seniors on Medicare.

The report also comes at a time when the American Pharmaceutical industry and the Bush Administration are waging anall out campaign against poorer nations such as Brazil and South Africa that want to manufacture generic equivalentsof life-saving drugs.

We invited representatives of the Pharmaceutical Research Manufacturers of America numerous times to be on the show,but they declined. They have denounced the findings of the Public Citizen report and criticized its methodology.

Guest:

  • Frank Clemente, head of Public Citizen’s Congress Watch.

Related link:


Creative Commons License The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to democracynow.org. Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.

This is viewer supported news